F9 Cells

The F9 cell line, a murine embryonal carcinoma model derived from a testicular teratoma of the C57BL/6 mice, serves as an important tool in developmental biology and embryology. F9 cells are capable of differentiation into parietal endoderm when exposed to retinoic acid and dibutyryl cyclic AMP (cAMP). This differentiation is marked by significant changes in cellular behavior and protein expression, including the synthesis of plasminogen activator, laminin, and type IV collagen. These proteins are crucial for understanding the processes of tissue development and matrix formation in early embryonic stages. It is noted that cAMP's effectiveness in inducing differentiation in F9 cells is conditional upon prior treatment with retinoic acid, indicating a complex interplay between these signaling molecules in triggering developmental pathways. Additionally, F9 cells are characterized by having three copies of the beta 1 integrin gene, which may influence cell adhesion and mobility, further underscoring their utility in studying cell interactions and extracellular matrix composition. Safety profiling of these cells includes testing for ectromelia virus (mousepox), for which they have been found negative, ensuring their suitability for a broad range of experimental applications without the risk of viral contamination. Mouse cell lines, Testis, Teratocarcinoma, Growth Conditions: Adherent, Biosafety level: BSL 1